RNS27 Jun 2018 08:35
Key highlights:
· Successful integration of three of the four key LIGHT system structures significantly reducing technical risk
· Technological development on-track to be capable of treating superficial tumours by the end of Q3 this year
· Science and Technology Facilities Council agreement to establish a UK testing and assembly site
· Harley Street site building work on schedule, first patient treatment expected by the second half of 2020
· Commercial distribution agreement with Yantai CIPU for China and other parts of Asia
· Stronger financial position since 31st December 2017 having secured £33.3m of financing post period end
· Ongoing commercial discussions with sites in the USA, Europe, Asia and Middle East